We are live on ! Find out more
CP

Catalys Pacific Portfolio holdings

AUM $231M
1-Year Est. Return 83.19%
This Fund
S&P 500
This Quarter Est. Return
-25.9%
1 Year Est. Return
+83.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$231M
AUM Growth
-$79.8M
Cap. Flow
+$819K
Cap. Flow %
0.35%
Top 10 Hldgs %
100%
Holding
2
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
PHAT icon
Phathom Pharmaceuticals
PHAT
+$819K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLYS icon
1
Mineralys Therapeutics
MLYS
$2.34B
$214M 92.81%
7,903,838
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$687M
$16.6M 7.19%
1,493,854
+64,840
+5% +$819K

Similar funds

Catalys Pacific's Q1 2026 Portfolio in Review

As of Q1 2026, Catalys Pacific held 2 positions worth $231M, down 26% from $311M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 0%. Catalys Pacific opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Catalys Pacific added most to Phathom Pharmaceuticals in Q1 2026, an estimated $819K increase.
  • Catalys Pacific's ten largest holdings make up 100% of its $231M portfolio in Q1 2026.
  • Catalys Pacific opened 0 new positions and closed 0 in Q1 2026.
  • Catalys Pacific's portfolio value fell 26% quarter-over-quarter to $231M.

Based on Catalys Pacific's 13F filing for Q1 2026, filed 14 May 2026.